|
|
|
|
|
|
|
|
|
|
Carboplatin injection (600mg/60mL) - Advisories, Warnings & Recalls for hospitals
Affected lot of Carboplatin subject to recall from the Canadian market:
Z011710AB: Expiry date: August 2013
- In the event where particulate matter is injected into a patient, there is the potential for patient injury.
- Vials of the affected lot should not be used and should be returned to Hospira.
- Since the particulate matter is formed from carboplatin crystals, the efficacy of drug product from this lot may be reduced.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.